India, May 21 -- Today's gainers include CODX, which rallied for the third straight day; Akari, on breakthrough clinical data in pancreatic cancer; Sunshine, following regulatory approval for its generic Amoxicillin; GOVX, amid Ebola concerns; and RGNX, on upcoming clinical trial milestones, among others.
CODX Extends Rally
Co-Diagnostics Inc. (CODX) gained another 55% on Thursday, topping the list of today's gainers. The stock has been on fire since May 19, 2026, after the company announced it had completed the assay development strategy for the Bundibugyo virus ("BDBV"), which is currently causing an outbreak of Ebola disease in the Democratic Republic of the Congo and Uganda.
CODX closed Thursday's trading at $3.71, up 55.23%.
AKTX -...